ENHO and diabetes mellitus: Our immunofluorescence results showed a significant decrease in the percentage of α-cells in adropin-treated diabetic rats, and our immunoelectron microscopy results also revealed a decrease in the percentage of granules containing adropin and glucagon in that same animal group, suggesting the ability of adropin to regulate glucagon secretion in diabetes.